99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast Cancer
NCT04267900
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
99mTc-HPArk2
Sponsor
Peking Union Medical College Hospital